Actively Recruiting
Transaxillary TAVR With Solely Echocardiography Guidance
Led by Chinese Academy of Medical Sciences, Fuwai Hospital · Updated on 2026-02-27
20
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).
CONDITIONS
Official Title
Transaxillary TAVR With Solely Echocardiography Guidance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Symptomatic severe aortic stenosis confirmed by echocardiography and Doppler, requiring aortic valve replacement, defined as mean gradient ≥40 mmHg, peak aortic velocity ≥4 m/s, and aortic valve area ≤1 cm² or indexed AVA ≤0.6 cm²/m²
- Suitable for transaxillary transcatheter aortic valve replacement (TAVR)
You will not qualify if you...
- Need for hybrid procedures or additional interventions on other heart defects
- Inoperable due to extremely high surgical risk or severe other medical conditions
- Untreated clinically significant (greater than 70% blockage) proximal coronary artery disease that can be treated
- Previous aortic valve replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
X
Xiangbin Pan, MD
CONTACT
X
Xu Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here